ITP - IMMUNE THROMBOCYTOPENIA
Clinical trials for ITP - IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new ITP - IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for ITP - IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene-Edited cells take aim at stubborn autoimmune diseases
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called CTX112 for adults with two serious autoimmune blood disorders: immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA). These conditions cause the immune system to attack the body's own blood cells. CTX11…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 26, 2026 08:15 UTC
-
New combo may let ITP patients stay off meds longer
Disease control Not yet recruitingThis study tests whether adding all-trans retinoic acid (ATRA) to the standard drug avatrombopag helps adults with immune thrombocytopenia (ITP) maintain safe platelet levels after stopping treatment. About 248 people whose ITP did not improve with first therapy or came back will…
Matched conditions: ITP - IMMUNE THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 22, 2026 13:53 UTC